Corporate philanthropy, lobbying, and public health policy.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 18923118.
- Also identified by DOI 10.2105/AJPH.2007.128231 and PMC identifier 2636524.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To counter negative publicity about the tobacco industry, Philip Morris has widely publicized its philanthropy initiatives. Although corporate philanthropy is primarily a public relations tool, contributions may be viewed as offsetting the harms caused by corporate products and practices. That such donations themselves have harmful consequences has been little considered. Drawing on internal company documents, we explored the philanthropy undertaken as part of Philip Morris's PM21 image makeover. Philip Morris explicitly linked philanthropy to government affairs and used contributions as a lobbying tool against public health policies. Through advertising, covertly solicited media coverage, and contributions to legislators' pet causes, Philip Morris improved its image among key voter constituencies, influenced public officials, and divided the public health field as grantees were converted to stakeholders.
Medical subject headings
- Advertising
- Fund Raising
- Lobbying
- Public Health
- Social Marketing
- Tobacco Industry